Artificial intelligence applications in inflammatory bowel disease: Emerging technologies and future directions

Area of Science:

• Gastroenterology and Computational Biology
• Focuses on Inflammatory Bowel Disease (IBD) research utilizing advanced computational methods.

Background:

• Inflammatory Bowel Disease (IBD) incidence is rising globally, causing significant patient morbidity.
• Large datasets from electronic health records, multi-omics, and imaging offer new insights into IBD.
• Artificial intelligence (AI) facilitates the analysis and interpretation of these complex IBD datasets.

Purpose of the Study:

• To review recent advancements in AI and machine learning applications for IBD.
• To summarize AI's role in IBD diagnosis, risk prediction, and disease severity assessment.
• To explore AI's utility in predicting clinical outcomes for patients with IBD.

Main Methods:

• Analysis of recent literature on AI and machine learning in Inflammatory Bowel Disease.
• Integration of multi-omics data (genomics, proteomics, metagenomics) with AI algorithms.
• Review of AI applications in analyzing electronic health records and medical imaging for IBD.

Main Results:

• AI facilitates the analysis and integration of large, heterogeneous datasets in IBD research.
• AI shows promise in improving diagnosis, risk stratification, and outcome prediction in IBD.
• Current barriers include AI method heterogeneity and the need for prospective validation studies.

Conclusions:

• AI and machine learning are powerful tools for advancing IBD research and clinical care.
• Further unbiased validation studies are crucial for the clinical adoption of AI in IBD management.
• AI holds significant potential to address unmet needs in the diagnosis and treatment of IBD.